S1 Data - by Ibrahim T. El-Ratel (16535296)

Subjects:

Decreasing trends in HbA1c are visible when using the average HbA1c for each dataset for T1Ds, but not T2Ds. by Hans F. Dias (14486401)

DataSheet_1_Decrease in Serum Urate Level Is Associated With Loss of Visceral Fat in Male Gout Patients.docx by Zijing Ran (11429935)

“…Subjects included had all been treated with urate-lowering therapy (ULT) (febuxostat 20–80 mg/day or benzbromarone 25–50 mg/day, validated by the medical record). …”

Errors and false starts on the PVT decrease following acclimatization. by Erica C. Heinrich (6832055)

DataSheet_1_Complement inhibition can decrease the haemostatic response in a microvascular bleeding model at multiple levels.xlsx by Murielle Golomingi (13239774)

Data for Figs S1A–S1C, S2A, S2C–S2L, S3C–S3F, S4A–S4J. by Xiaohua Zhang (350570)

Effect of NAC on cell proliferation in C2C12 myoblasts. by Yi-Xuan Li (6633845)

2‑Aminobenzoxazole Derivatives as Potent Inhibitors of the Sphingosine-1-Phosphate Transporter Spinster Homolog 2 (Spns2) by Ariel L. Burgio (15069256)

“…To develop more potent compounds, we initiated a structure–activity relationship study that identified 2-aminobenzoxazole as a viable scaffold. …”

Table_1_Empagliflozin Decreases Lactate Generation in an NHE-1 Dependent Fashion and Increases α-Ketoglutarate Synthesis From Palmitate in Type II Diabetic Mouse Hearts.DOCX by Hong Zhang (25820)

“…However, EMPA did specifically decrease cardiac lactate labeling in the ¹³C glucose perfusions (¹³C labeling of lactate: 58 ± 2% vs. 50 ± 3%, for vehicle and EMPA, respectively; P = 0.02), without changes in other glucose metabolic pathways. …”

Supplemental Material for MSG L-00273-2023R1;Hemopexin Reverses Activation of Lung eIF2a and Decreases Mitochondrial Injury in Chlorine Exposed Mice by Sadis Matalon (13571353)

Loss of EBNA3C-CtBP binding decreases p300 occupancy at promoters of EBNA3C induced genes. by Makoto Ohashi (104612)

Effect of selected feed additives to improve growth and health of dairy calves by Luisa F. L. Salazar (6664121)

“…The treatments were: control (CON), monensin (MON; 30 mg/kg of starter), probiotic <i>E</i>. <i>faecium</i> (PROB; 70 mg/kg of starter), essential oils (EO; 300 mg/kg of starter), or PROB + EO (EOPROB). …”

Locations of refugia with 2°C and 4.5°C warming. by Rhosanna L. M. Jenkins (11167230)

Increased sensitivity to amphetamine and decreased sensitivity diazepam cKO mice. by Robert Fredriksson (27811)

Decreased phosphorylation of EIF2α underlies the impairment of arsenite-induced SG formation in LSM12-depleted cells. by Jongbo Lee (9914603)

“…(B, C) LSM12 depletion decreases the arsenite-induced phosphorylation of EIF2α. …”

Comparison of the decrease of CFU in CSF and blood between treatment groups within the first 6 h after treatment. by Luca G. Valente (12463057)

DAF-16/FOXO is Required for Locomotory Healthspan and Lifespan Benefits of Genetic Glycolysis Disruption. by Brian Onken (86790)

“…(C) Survival curves of <i>daf-16(mgDf50)</i> null mutants treated with RNAi against glycolytic genes <i>pfk</i> and <i>pyk-2</i>. …”

Disrupting Glycolysis-promoting Genes Extends <i>C</i>. <i>elegans</i> Healthspan, Whereas High Glucose and Gluconeogenic Gene Disruptions Shorten Healthspan. by Brian Onken (86790)

“…We note that, in our hands, disruption of C50F4.2 (<i>pfk-1</i>.…”

Effect of atipamezole or efaroxan (1 mg·kg⁻¹) (Protocol 2). by Yoichiro Kitajima (4319455)

Quantitative 3C (3C-qPCR) analysis confirmed decreased frequencies of chromatin looping. by Hiroko Yaguchi (18086827)